Omidenepag: A New Category of Topical Glaucoma Therapy

Drs. Amanda Bicket and Lori Provencher join Dr. Andrew Pouw to discuss omidenepag isopropyl (Omlonti), the recently FDA-approved eye drop for treating elevated IOP in patients with primary open-angle glaucoma or ocular hypertension. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.